Skip to main content
. Author manuscript; available in PMC: 2023 Jun 5.
Published in final edited form as: Prog Cardiovasc Dis. 2022 Aug 8;74:19–27. doi: 10.1016/j.pcad.2022.08.003

Table 3.

Hazard ratios (95% confidence interval) for the association of polygenic risk scores and incident atherosclerotic cardiovascular disease, coronary heart disease and stroke overall and stratified by sex and race/ethnicity.

ASCVD CHD Stroke



Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
Overall
 ASCVD PRS 1.77 (1.20,2.60) 1.70 (1.16,2.49) 1.63 (1.11,2.39) 1.61 (0.98,2.66) 1.54 (0.94,2.53) 1.45 (0.88,2.38) 1.77 (0.99,3.17) 1.72 (0.96,3.06) 1.71 (0.95,3.06)
 CHD PRS 0.99 (0.66,1.51) 0.98 (0.65,1.49) 0.94 (0.62,1.43) 0.92 (0.54,1.55) 0.91 (0.54,1.53) 0.87 (0.51,1.47) 1.05 (0.55,2.00) 1.06 (0.55,2.02) 1.04 (0.54,1.98)
 Stroke PRS 1.84 (1.27,2.68) 1.88 (1.29,2.73) 1.84 (1.27,2.68) 1.87 (1.10,3.18) 1.86 (1.09,3.18) 1.79 (1.05,3.06) 1.91 (1.16,3.15) 1.97 (1.20,3.24) 1.96 (1.19,3.23)
Men
 ASCVD PRS 1.29 (0.68,2.47) 1.32 (0.69,2.50) 1.29 (0.68,2.45) 1.08 (0.48,2.43) 1.13 (0.51,2.54) 1.11 (0.50,2.49) 1.77 (0.62,5.04) 1.76 (0.63,4.90) 1.74 (0.62,4.89)
 CHD PRS 0.77 (0.40,1.47) 0.77 (0.40,1.48) 0.77 (0.40,1.46) 0.66 (0.30,1.47) 0.68 (0.31,1.52) 0.68 (0.30,1.50) 0.98 (0.32,2.99) 1.05 (0.35,3.10) 1.09 (0.36,3.29)
 Stroke PRS 0.82 (0.43,1.54) 0.76 (0.40,1.45) 0.76 (0.40,1.44) 0.57 (0.22,1.46) 0.54 (0.21,1.38) 0.53 (0.21,1.36) 1.30 (0.56,2.99) 1.25 (0.54,2.91) 1.25 (0.54,2.91)
Women
 ASCVD PRS 2.04 (1.24,3.35) 1.96 (1.20,3.21) 1.83 (1.11,3.02) 2.01 (1.04,3.07) 1.90 (0.99,3.64) 1.68 (0.87,3.25) 1.77 (0.86,3.61) 1.70 (0.84,3.47) 1.70 (0.83,3.49)
 CHD PRS 1.23 (0.72,2.11) 1.22 (0.71,2.08) 1.13 (0.66,1.94) 1.22 (0.60,2.47) 1.18 (0.58,2.39) 1.08 (0.53,2.21) 1.13 (0.52,2.44) 1.13 (0.52,2.43) 1.08 (0.50,2.35)
 Stroke PRS 2.90 (1.81,4.65) 3.10 (1.93,4.98) 3.03 (1.88,4.87) 3.54 (1.77,7.07) 3.60 (1.80,7.20) 3.42 (1.71,6.83) 2.50 (1.35,4.64) 2.79 (1.49,5.23) 2.78 (1.48,5.19)
Whites
 ASCVD PRS 1.36 (0.76,2.43) 1.34 (0.74,2.40) 1.23 (0.68,2.21) 1.61 (0.81,3.21) 1.58 (0.79,3.14) 1.41 (0.70,2.83) 1.05 (0.37,2.96) 1.03 (0.37,2.91) 0.97 (0.35,2.75)
 CHD PRS 0.91 (0.49,1.68) 0.90 (0.49,1.67) 0.85 (0.46,1.57) 1.12 (0.53,2.35) 1.11 (0.53,2.34) 0.98 (0.46,2.08) 0.73 (0.27,1.97) 0.73 (0.27,1.97) 0.73 (0.27,1.99)
 Stroke PRS 1.57 (0.84,2.91) 1.53 (0.82,2.84) 1.49 (0.80,2.78) 2.23 (1.02,2.91) 2.15 (0.98,4.72) 2.06 (0.94,4.54) 1.17 (0.47,2.92) 1.16 (0.46,2.89) 1.14 (0.46,2.87)
Non-Whites
 ASCVD PRS 2.12 (1.28,3.51) 2.11 (1.29,3.46) 2.09 (1.27,3.43) 1.09 (0.53,2.21) 1.12 (0.57,2.23) 1.10 (0.55,2.18) 3.64 (1.80,7.34) 3.50 (1.75,6.99) 3.69 (1.83,7.42)
 CHD PRS 1.31 (0.77,2.24) 1.24 (0.73,2.11) 1.23 (0.73,2.10) 0.87 (0.41,1.85) 0.82 (0.41,1.85) 0.82 (0.39,1.74) 1.85 (0.88,3.91) 1.81 (0.87,3.75) 1.89 (0.90,3.94)
 Stroke PRS 1.90 (1.21,2.96) 2.00 (1.28,3.11) 1.97 (1.26,3.07) 1.51 (0.78,2.93) 1.56 (0.81,3.01) 1.52 (0.79,2.92) 2.27 (1.25,4.11) 2.40 (1.33,4.33) 2.39 (1.32,4.32)

Abbreviations: PRS (polygenic risk score); ASCVD (atherosclerotic cardiovascular disease), CHD (coronary heart disease); PC (principal component).

Model 1: age, sex, race/ethnicity, PC1-PC5.

Model 2: age, sex, race/ethnicity, principal components 1–5, education, Pooled Cohort Equations.

Model 3: age, sex, race/ethnicity, principal components 1–5, education, Pooled Cohort Equations, family history of premature coronary heart disease. Sx was not adjusted for in sex-stratified analyses.

Bolded items are significant.